(Senior) Director New Product Planning
Incyte
- Location
- Morges, VD
- Work model
- On-Site
- Level
- Staff
- H-1B history
- 10 approvals (FY2023)
About this role
Overview Build the Future of Hematology & Oncology International Hematology & Oncology is entering a defining chapter. As our portfolio expands across hematologic malignancies and solid tumors, we are building the commercial platform that will establish International as a major driver of Incyte's future growth. This is an opportunity to shape strategy years before launch, influence global decisions, and help bring transformational innovation to patients worldwide. The work you do today will help determine the success of tomorrow's pipeline.
Why this role matters Building a successful oncology franchise begins long before a medicine reaches patients. It begins with the strategic decisions that shape development, define differentiation, anticipate market needs and create long-term value. As Director, International New Product Planning, you will operate where science, strategy and commercial excellence intersect. Working across Global Development, Medical Affairs, Market Access and Commercial, you will help shape how future assets are developed, positioned and brought to markets around the world. Beyond individual products, you will contribute to building an International organization that increasingly influences global portfolio decisions and strengthens Incyte's leadership in Hematology & Oncology.
Your Mission Shape the commercial future of our Hematology & Oncology pipeline by transforming scientific innovation into differentiated, globally competitive medicines that create meaningful value for patients, healthcare systems and Incyte.
Where You Will Make an Impact Shape Future Assets The strongest launches begin years before approval. You will influence the commercial direction of pipeline assets from the earliest stages of development, ensuring International perspectives help shape global decisions. You will:
Develop integrated commercial strategies for priority Hematology and Oncology assets across International markets. Shape Target Product Profiles by identifying opportunities for meaningful clinical and commercial differentiation. Influence development strategies through market insights, competitive intelligence and evolving treatment landscapes. Partner with Clinical Development to help optimize trial design, evidence generation and market relevance. Build strategic recommendations that strengthen portfolio prioritization and long-term asset value.
Transform Innovation into Commercial Opportunity Scientific innovation creates opportunity. Commercial strategy unlocks its full potential. You will:
Build robust forecasting, valuation and scenario-planning models to support strategic investment decisions. Define differentiated value propositions for physicians, patients, healthcare systems and payers. Assess market opportunities, competitive dynamics and future treatment paradigms across International markets. Partner with Market Access and HEOR to shape pricing, reimbursement and evidence-generation strategies. Identify opportunities to maximize long-term lifecycle value across the portfolio.
Influence Enterprise Strategy International is becoming an increasingly important voice in shaping the future of our portfolio. You will help strengthen that influence by building alignment across senior stakeholders and translating complex information into clear strategic direction. You will:
Represent International Commercial within cross-functional governance and asset teams. Influence strategic decisions across Development, Medical Affairs, Commercial and Market Access. Build alignment across regional and affiliate organizations around one integrated commercial vision. Challenge assumptions through thoughtful analysis and forward-looking strategic thinking. Contribute to portfolio decisions that strengthen International's role as a key growth engine for Incyte.
Build Winning Launch Strategies Every successful launch builds the platform for the next